Literature DB >> 17540311

[Cost of dialysis in France].

Jean-Philippe Benain1, Bernadette Faller, Claude Briat, Christian Jacquelinet, Michèle Brami, Martine Aoustin, Jean-Pierre Dubois, Philippe Rieu, Cecile Behaghel, Gérard Duru.   

Abstract

The provision of care for patients with end-stage chronic renal failure is an important medical and economic challenge for the Health Insurance. Previous studies have shown a lower cost for home dialysis. More recently, studies have confirmed identical short-term survival rates between haemodialysis and peritoneal dialysis. Notwithstanding, home dialysis techniques utilization remains weak in France. This work aims at: determining the average annual cost of dialysis, per patient and per technique of dialysis, and assessing the global annual cost of dialysis in France, from the Health Insurance perspective. Methodologically, this article provides a static estimation of the cost of dialysis. Costs related to co-morbidities of end-stage chronic renal failure have not been considered. Standard patient care schemes have been outlined by a multidisciplinary expert committee, for each dialysis technique, and have been valorised using publicly available data and tariffs recorded in 2005. Our result show that home dialysis techniques are the less costly, with an average annual cost per patient of 49.9, 49.7 and 50.0 k euro respectively for home haemodialysis, automated peritoneal dialysis, and continuous ambulatory peritoneal dialysis. Autodialysis, autonomous in-center haemodialysis and in-center haemodialysis respectively cost 59.5, 62.3 and 81.5 k euro per patient and per annum. The total 2005 cost of dialysis for the Health Insurance is estimated at 2.1 billion euro. Therefore, the development of alternative techniques to in-center haemodialysis, such as home dialysis or autonomous in-center haemodialysis, autodialysis being already well developed, could generate savings for the Health Insurance. From the patient's perspective, it could also allow the enlightened choice of the best customized technique, less guided by local offer than by medical or social criteria, as well as by the patient's own opinion.

Entities:  

Mesh:

Year:  2007        PMID: 17540311     DOI: 10.1016/j.nephro.2007.03.001

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  7 in total

1.  Caregiver burden and hemodialysis.

Authors:  Lewis M Cohen; Michael J Germain
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

2.  The direct cost of dialysis supported by families for patients with chronic renal failure in Ouagadougou (Burkina Faso).

Authors:  Amadou Oury Toure; Mamadou Dioulde Balde; Aissatou Diallo; Sadan Camara; Anne Marie Soumah; Alpha Oumar Sall; Karifa Kourouma; Bienvenu Salim Camara; Fadima Yaya Bocoum; Seni Kouanda
Journal:  BMC Nephrol       Date:  2022-06-23       Impact factor: 2.585

3.  A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.

Authors:  Anne-Line Couillerot-Peyrondet; Cléa Sambuc; Yoël Sainsaulieu; Cécile Couchoud; Isabelle Bongiovanni-Delarozière
Journal:  Eur J Health Econ       Date:  2016-05-05

4.  Educating end-stage renal disease patients on dialysis modality selection.

Authors:  Adrian Covic; Bert Bammens; Thierry Lobbedez; Liviu Segall; Olof Heimbürger; Wim van Biesen; Denis Fouque; Raymond Vanholder
Journal:  NDT Plus       Date:  2010-04-16

5.  Effects of educational practices on the peritonitis risk in peritoneal dialysis: a retrospective cohort study with data from the French peritoneal Dialysis registry (RDPLF).

Authors:  Hélène Bonnal; Clémence Bechade; Annabel Boyer; Thierry Lobbedez; Sonia Guillouët; Christian Verger; Maxence Ficheux; Antoine Lanot
Journal:  BMC Nephrol       Date:  2020-05-29       Impact factor: 2.388

6.  'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.

Authors:  Charlotte Logeman; Yeoungjee Cho; Benedicte Sautenet; Gopala K Rangan; Talia Gutman; Jonathan Craig; Albert Ong; Arlene Chapman; Curie Ahn; Helen Coolican; Juliana Tze-Wah Kao; Ron T Gansevoort; Ronald Perrone; Tess Harris; Vincent Torres; Kevin Fowler; York Pei; Peter Kerr; Jessica Ryan; David Johnson; Andrea Viecelli; Clair Geneste; Hyunsuk Kim; Yaerim Kim; Martin Howell; Angela Ju; Karine E Manera; Armando Teixeira-Pinto; Gayathri Parasivam; Allison Tong
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

7.  Unmet needs for CKD care: from the general population to the CKD clinics-how many patients are we missing?

Authors:  Massimo Torreggiani; Antoine Chatrenet; Antioco Fois; Jean Philippe Coindre; Romain Crochette; Mickael Sigogne; Samuel Wacrenier; Guillaume Seret; Béatrice Mazé; Léna Lecointre; Conrad Breuer; Hafedh Fessi; Giorgina Barbara Piccoli
Journal:  Clin Kidney J       Date:  2021-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.